Latest Period
Q2 2026
Security Snapshot
ACHIEVE LIFE SCIENCES, INC. - Common Stock (ACHV) Institutional Ownership
CUSIP: 004468500
13F Institutional Holders and Ownership History from Q3 2020 to Q2 2026
Institutions Reporting
109
Shares (Excl. Options)
82,472,984
Price
$6.53
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock
- Symbol
- ACHV on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 82,472,984
- Total 13F value
- $538,512,220
- Portfolio coverage rank
- 0%
- Share change
- +58,088,729
- Value change
- +$387,937,293
- Number of holders
- 109
- Shares outstanding
- 105,489,890
- SEC-reported price per share
- $6.30
- Insider filing price
- $6.30
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- ACHV - ACHIEVE LIFE SCIENCES, INC. - Common Stock is tracked under CUSIP 004468500.
- 109 institutions reported positions in Q2 2026.
- 13 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 79 to 109 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $63,555,449 to $538,512,220.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 109 institutions filings for Q2 2026.
Security key
004468500
Latest holder period
Q2 2026
13F holders
109
13D/G owners
13
CIK / CUSIP context first
Open Q2 2026 holders
ACHV full holder history
ACHIEVE LIFE SCIENCES, INC. SEC filings
ACHIEVE LIFE SCIENCES, INC. company facts
ACHIEVE LIFE SCIENCES, INC. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 004468500:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
13
Security
ACHV
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| TPG GP A, LLC | 13% | $40,440,170 | 13,755,160 | TPG GP A, LLC | 17 Apr 2025 | |||
| venBio Global Strategic Fund V, L.P. | 10% | $31,567,712 | 10,737,317 | venBio Global Strategic Fund V, L.P. | 15 Apr 2026 | |||
| Logos Global Management LP | 10% | $64,284,484 | 10,538,440 | Logos Global Management LP | 11 May 2026 | |||
| Paradigm Biocapital Advisors LP | 9.2% | $29,116,913 | 9,903,712 | Paradigm BioCapital Advisors LP | 17 Apr 2026 | |||
| FRANKLIN RESOURCES INC | 8.3% | +35% | $57,979,491 | +$16,388,276 | 8,878,942 | +39% | Franklin Resources, Inc. | 30 Jun 2026 |
| Frazier Life Sciences Public Fund, L.P. | 6.5% | $19,479,817 | 6,625,788 | Frazier Life Sciences Public Fund, L.P. | 17 Apr 2026 | |||
| Venrock Healthcare Capital Partners III, L.P. | 5.2% | $16,176,068 | 5,502,064 | Venrock Healthcare Capital Partners III, L.P. | 17 Apr 2026 | |||
| Janus Henderson Group Ltd. | 5.4% | $33,562,590 | 5,502,064 | JANUS HENDERSON GROUP Ltd. | 30 Jun 2026 | |||
| Vivo Opportunity Fund Holdings, L.P. | 5% | $29,287,133 | 5,305,640 | Vivo Opportunity, LLC | 06 Jul 2026 | |||
| BlackRock, Inc. | 5.1% | +450% | $34,422,183 | +$32,367,199 | 5,271,391 | +1575% | BlackRock, Inc. | 30 Jun 2026 |
| Alyeska Investment Group, L.P. | 5.6% | -43% | $9,395,574 | -$6,098,715 | 2,982,722 | -39% | Alyeska Investment Group, L.P. | 30 Sep 2025 |
| Contrarian Alpha, LP | 4.9% | $7,964,388 | 2,528,377 | Parker Quillen | 30 Sep 2025 | |||
| VANGUARD GROUP INC | 5% | $4,086,493 | 1,717,014 | The Vanguard Group | 31 Mar 2025 |
As of 30 Jun 2026, 109 institutional investors reported holding 82,472,984 shares of ACHIEVE LIFE SCIENCES, INC. - Common Stock (ACHV). This represents 78% of the company’s total 105,489,890 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
73%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 7.2% | 7,614,836 | 1.1% | $49,724,879 | |
| TPG GP A, LLC | 6.5% | 6,877,580 | 0.9% | $44,910,597 | |
| venBio Partners LLC | 5.6% | 5,914,720 | 7.4% | $38,623,122 | |
| Logos Global Management LP | 5.1% | 5,425,000 | 1.5% | $35,425,250 | |
| BlackRock, Inc. | 5% | 5,272,017 | +1100% | 0% | $34,426,271 |
| FRANKLIN RESOURCES INC | 4.7% | 4,953,220 | +13% | 0.01% | $32,344,527 |
| Paradigm Biocapital Advisors LP | 4.7% | 4,951,856 | 0.61% | $32,335,620 | |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.9% | 4,140,812 | +88% | 0% | $27,039,502 |
| Propel Bio Management, LLC | 3.8% | 4,034,018 | +6.5% | 14% | $26,342,138 |
| MARSHALL WACE, LLP | 3.6% | 3,770,313 | +270% | 0.02% | $24,620,145 |
| STATE STREET CORP | 2.8% | 2,945,526 | +1058% | 0% | $19,234,285 |
| Jupiter Topco LLC | 2.6% | 2,751,032 | 0% | 0.01% | $17,964,239 |
| Venrock Adviser, LLC | 2.6% | 2,751,032 | 0.54% | $17,964,239 | |
| Vivo Capital, LLC | 2.6% | 2,751,032 | 1.6% | $17,964,239 | |
| EVENTIDE ASSET MANAGEMENT, LLC | 2.1% | 2,220,000 | 0.19% | $14,496,600 | |
| GEODE CAPITAL MANAGEMENT, LLC | 2% | 2,062,721 | +231% | 0% | $13,471,818 |
| Alyeska Investment Group, L.P. | 1.8% | 1,925,722 | 0.03% | $12,574,965 | |
| Simplify Asset Management Inc. | 1.4% | 1,432,105 | +21% | 0.13% | $9,351,646 |
| WELLINGTON MANAGEMENT GROUP LLP | 1.4% | 1,426,915 | 0% | $9,317,755 | |
| LPL Financial LLC | 0.86% | 902,255 | +24% | 0% | $5,891,725 |
| NORTHERN TRUST CORP | 0.71% | 743,760 | +231% | 0% | $4,856,753 |
| Spruce Street Capital LP | 0.7% | 736,637 | 0.94% | $4,810,240 | |
| VANGUARD FIDUCIARY TRUST CO | 0.56% | 593,751 | +88% | 0% | $3,877,194 |
| RAYMOND JAMES FINANCIAL INC | 0.52% | 546,318 | -15% | 0% | $3,567,457 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 0.51% | 537,596 | 0% | $3,510,502 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
24
Latest
Q2 2026
Rows shown
1-24 of 24
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 82,472,984 | $538,512,220 | +$387,937,293 | $6.53 | 109 |
| 2026 Q1 | 21,523,954 | $63,555,449 | -$6,062,639 | $2.94 | 79 |
| 2025 Q4 | 23,239,545 | $115,291,318 | +$36,552,641 | $4.97 | 77 |
| 2025 Q3 | 15,541,415 | $48,917,159 | -$26,338,868 | $3.15 | 65 |
| 2025 Q2 | 26,238,674 | $59,299,106 | +$26,395,211 | $2.26 | 64 |
| 2025 Q1 | 14,388,656 | $38,412,610 | -$6,420,566 | $2.67 | 72 |
| 2024 Q4 | 16,340,748 | $57,510,675 | -$2,280,524 | $3.52 | 70 |
| 2024 Q3 | 16,929,998 | $81,217,159 | +$2,394,591 | $4.74 | 64 |
| 2024 Q2 | 12,513,128 | $58,811,518 | +$9,414,756 | $4.70 | 54 |
| 2024 Q1 | 10,495,260 | $47,701,835 | +$35,368,247 | $4.54 | 39 |
| 2023 Q4 | 2,727,493 | $11,236,940 | -$1,729,113 | $4.12 | 29 |
| 2023 Q3 | 3,117,219 | $13,403,691 | -$2,279,792 | $4.30 | 35 |
| 2023 Q2 | 3,562,232 | $18,487,663 | +$5,645,131 | $5.19 | 38 |
| 2023 Q1 | 2,470,554 | $16,600,668 | +$3,392,110 | $6.80 | 31 |
| 2022 Q4 | 1,999,698 | $4,902,826 | -$458,841 | $2.45 | 27 |
| 2022 Q3 | 2,121,733 | $7,001,230 | +$176,107 | $3.30 | 28 |
| 2022 Q2 | 2,043,015 | $9,968,000 | -$109,417 | $4.88 | 31 |
| 2022 Q1 | 1,932,821 | $14,633,000 | -$2,149 | $7.57 | 33 |
| 2021 Q4 | 1,918,795 | $14,925,000 | +$535,636 | $7.78 | 26 |
| 2021 Q3 | 1,782,658 | $15,149,000 | -$1,185,059 | $8.50 | 30 |
| 2021 Q2 | 1,948,272 | $17,498,000 | +$7,592,533 | $8.98 | 28 |
| 2021 Q1 | 1,007,113 | $11,662,000 | +$6,322,912 | $11.58 | 16 |
| 2020 Q4 | 493,003 | $3,994,000 | +$307,274 | $8.10 | 14 |
| 2020 Q3 | 452,590 | $3,789,000 | +$3,789,000 | $8.37 | 12 |